MAY 18, 2021 5:00 AM PDT

HbA1c: past, present and future

Sponsored by: Abbott
C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

Date:  May 18, 2021

Time: 5:00am PST, 2:00pm CEST

 

Since its discovery in the late 60s, HbA1c, the major form of glycated haemoglobin, has been widely used in laboratories as a key biomarker of glycemic control in patients with diabetes over the four to eight weeks preceding blood collection.

Many methods based on different principles (ion exchange HPLC, capillary electrophoresis, immunoassay, affinity, enzymatic methods) have been developed for assaying HbA1c, necessitating an international standardization which was achieved by IFCC in the 2000s. All HbA1c methods are now traceable to the IFCC reference measurement procedure, and values of calibrators are assigned by an international network of reference laboratories. The development of external quality assessment schemes together with the standardization process have deeply improved the quality of results.

Meanwhile, several interlaboratory trials have shown that an important point in external quality assessment was the use of commutable control samples (same behavior as fresh whole blood from patients) in order to clearly assess the quality of the methods.

Most of the analytical challenges of HbA1c assays have been addressed, especially interferences (labile HbA1c or carbamylated Hb). However, different clinical situations need to be carefully considered like chronic kidney disease, because of the modifications of red blood cell lifespan due to chronic anemia and to the possible administration of erythropoietin, and of the occurrence of competing processes like carbamylation. Another situation is the presence of a hemoglobin variant.

The interference of the major variants has been well documented, but many less common variants may be encountered that interfere positively or negatively with results.

Finally, besides its role as gold standard in the survey of glycemic control, HbA1c is now used in many countries as a tool for diabetes diagnosis and/or screening, being interesting for its lower variability than glucose and achievable without fasting.

 

In this webinar, you will :

  • Discuss the different methods used for assaying HbA1C with their characteristics and performances.
  • Discuss and understand the importance of the use of commutable materials for external quality control assessment
  • Discuss the major pitfalls in HbA1c result interpretation, especially in case of renal diseases or hemoglobin variants, and the new indications of HbA1c in diabetes diagnosis.

 

 

 

 

Webinars will be available for unlimited on-demand viewing after live event.

 

LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


Show Resources
You May Also Like
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
APR 21, 2021 10:00 AM PDT
C.E. CREDITS
APR 21, 2021 10:00 AM PDT
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
SEP 16, 2021 8:00 AM PDT
C.E. CREDITS
SEP 16, 2021 8:00 AM PDT
Date: September 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) Rapid screening and speed of scale-up in protein therapeutics are critical factors in today’s biotech and pharma workflows. T...
JUN 03, 2021 12:00 PM CST
JUN 03, 2021 12:00 PM CST
DATE: June 3, 2021 TIME: 12:00pm SGT This webinar is a virtual event that focuses on utilizing the Gibco CTS Rotea System for Cell and Gene Therapy...
JUN 24, 2021 8:00 AM PDT
C.E. CREDITS
JUN 24, 2021 8:00 AM PDT
Date: June 24, 2021 Time: 8:00am (PDT), 11:00am (EDT) Cardiovascular disease is a leading health problem, affecting almost 30% of individuals in the developed world, and comprises a wide ran...
Loading Comments...
Show Resources